Tailor Made Compounding
Warning letteri (Apr 2020) cited a glutathione batch released at 88% labeled strength; no further FDA action found since.
About this pharmacy
Facility type: 503A compounding pharmacyi.
The four standards
Holds NABPi and LegitScript accreditation, per the company’s own published materials.
FDA warning letter issued April 1, 2020, citing release of an injectable glutathione batch at 88% of labeled strength, among other CGMPi violations. No closeout letteri has been found. No further FDA warning letter or enforcement action has been identified since.
(Method: checked against FDA’s public warning-letter and closeout-letter databases.)
Source: FDA warning letter — April 2020
Operates under its stated legal name, not private-label branding.
This standard has not yet been checked for this pharmacy.
Notes
This accreditation information predates the pharmacy’s 2026 acquisition by Noom and has not been independently reconfirmed post-acquisition.
Tailor Made Compounding LLC pleaded guilty to one count of distributing unapproved new drugs and was sentenced in the Eastern District of Kentucky. This is a separate matter from the FDA warning letter, reported here as a public fact.
Frequently asked questions
Is Tailor Made Compounding accredited?
Yes. Tailor Made Compounding holds NABP and LegitScript accreditation, per the company’s own published materials.
Has Tailor Made Compounding had any FDA regulatory actions?
Yes. FDA warning letter issued April 1, 2020, citing release of an injectable glutathione batch at 88% of labeled strength, among other CGMP violations. No closeout letter has been found. No further FDA warning letter or enforcement action has been identified since. Checked against FDA’s public warning-letter and closeout-letter databases.